Research / KMB / Fundamental state Inspectable configuration
State dimensions Filing 0000055785-19-000013 General Corporate
Debt relative to revenue RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.debt_to_revenue
33.79% · OPTIONAL · NOT_ENOUGH_HISTORY
Capex intensity RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.capex_revenue_ratio
4.74% · OPTIONAL · NOT_ENOUGH_HISTORY
Operating cash generation RAW Current state valid · history insufficient
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
16.07% · OPTIONAL · NOT_ENOUGH_HISTORY
Revenue growth RAW Current state valid · history insufficient
Evidence method Yoy · gp.fundamentals.revenue
1.24% · CORE · NOT_ENOUGH_HISTORY
Inventory pressure RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
9.81% · OPTIONAL · NOT_ENOUGH_HISTORY
Gross margin RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.gross_margin
30.28% · CORE · NOT_ENOUGH_HISTORY
Operating margin RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.operating_margin
12.06% · CORE · NOT_ENOUGH_HISTORY
R&D intensity RAW Current state valid · history insufficient
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
1.71% · OPTIONAL · NOT_ENOUGH_HISTORY
SBC intensity RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
0.22% · OPTIONAL · NOT_ENOUGH_HISTORY
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 38 states Self-history eligible
Sep 30, 2021 8/8 normalized Level 3 Dec 31, 2021 8/9 normalized Level 3 Mar 31, 2022 8/8 normalized Level 3 Jun 30, 2022 8/8 normalized Level 3 Sep 30, 2022 8/8 normalized Level 3 Dec 31, 2022 8/9 normalized Level 3 Mar 31, 2023 8/8 normalized Level 3 Jun 30, 2023 8/8 normalized Level 3 Sep 30, 2023 8/8 normalized Level 3 Dec 31, 2023 8/9 normalized Level 3 Mar 31, 2024 8/8 normalized Level 3 Jun 30, 2024 8/8 normalized Level 3 Sep 30, 2024 8/8 normalized Level 3 Dec 31, 2024 8/9 normalized Level 3 Mar 31, 2025 8/8 normalized Level 3 Jun 30, 2025 8/8 normalized Level 3 Sep 30, 2025 8/8 normalized Level 3 Dec 31, 2025 9/9 normalized Level 3 Mar 31, 2026 8/8 normalized Level 3 Jun 30, 2026 8/8 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Decreased
Previous 125.25%
Current 33.79%
Delta -91.46% Capex Intensity Decreased
Previous 4.78%
Current 4.74%
Delta -0.04% Cash Generation Increased
Previous 15.10%
Current 16.07%
Delta 0.96% Growth Increased
Previous -1.25%
Current 1.24%
Delta 2.49% Inventory Pressure Decreased
Previous 38.63%
Current 9.81%
Delta -28.82% Margin Decreased
Previous 30.90%
Current 30.28%
Delta -0.63% Profitability Decreased
Previous 14.60%
Current 12.06%
Delta -2.54% Sbc Intensity Decreased
Previous 0.41%
Current 0.22%
Delta -0.19% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.